These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8320961)
1. The study of human neoplastic disease in severe combined immunodeficient mice. Williams SS; Alosco TR; Croy BA; Bankert RB Lab Anim Sci; 1993 Apr; 43(2):139-46. PubMed ID: 8320961 [TBL] [Abstract][Full Text] [Related]
2. Quantitative comparison between the transplantability of human and murine tumors into the subcutaneous tissue of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Ruka W; Suit HD Cancer Res; 1993 Oct; 53(20):5012-7. PubMed ID: 8402692 [TBL] [Abstract][Full Text] [Related]
3. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511 [TBL] [Abstract][Full Text] [Related]
4. Quantitative comparison between the transplantability of human and murine tumors into the brain of NCr/Sed-nu/nu nude and severe combined immunodeficient mice. Taghian A; Budach W; Zietman A; Freeman J; Gioioso D; Suit HD Cancer Res; 1993 Oct; 53(20):5018-21. PubMed ID: 8402693 [TBL] [Abstract][Full Text] [Related]
5. Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. Garofalo A; Chirivi RG; Scanziani E; Mayo JG; Vecchi A; Giavazzi R Invasion Metastasis; 1993; 13(2):82-91. PubMed ID: 8225855 [TBL] [Abstract][Full Text] [Related]
6. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice. Beran M; Pisa P; Kantarjian H; Porwit A; Bjorkholm M Hematol Pathol; 1994; 8(4):135-54. PubMed ID: 7860433 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice. Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581 [TBL] [Abstract][Full Text] [Related]
8. Establishment of the hu-PBL-SCID mouse model for the investigation of thyroid cancer. Gyory F; Mezosi E; Szakall S; Bajnok L; Varga E; Borbely A; Gazdag A; Juhasz I; Lukacs G; Nagy EV Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):359-64. PubMed ID: 16025395 [TBL] [Abstract][Full Text] [Related]
9. A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID mice. Sato N; Gleave ME; Bruchovsky N; Rennie PS; Beraldi E; Sullivan LD Cancer Res; 1997 Apr; 57(8):1584-9. PubMed ID: 9108464 [TBL] [Abstract][Full Text] [Related]
10. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo. Chernicky CL; Yi L; Tan H; Gan SU; Ilan J Cancer Gene Ther; 2000 Mar; 7(3):384-95. PubMed ID: 10766344 [TBL] [Abstract][Full Text] [Related]
11. Establishment of a novel species- and tissue-specific metastasis model of human prostate cancer in humanized non-obese diabetic/severe combined immunodeficient mice engrafted with human adult lung and bone. Yonou H; Yokose T; Kamijo T; Kanomata N; Hasebe T; Nagai K; Hatano T; Ogawa Y; Ochiai A Cancer Res; 2001 Mar; 61(5):2177-82. PubMed ID: 11280783 [TBL] [Abstract][Full Text] [Related]
12. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547 [TBL] [Abstract][Full Text] [Related]
13. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model. Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246 [TBL] [Abstract][Full Text] [Related]
14. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector. Tanaka F; Abe M; Akiyoshi T; Nomura T; Sugimachi K; Kishimoto T; Suzuki T; Okada M Cancer Res; 1997 Apr; 57(7):1335-43. PubMed ID: 9102222 [TBL] [Abstract][Full Text] [Related]
15. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice]. Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235 [TBL] [Abstract][Full Text] [Related]
16. Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice. Mukuta T; Arreaza G; Nishikawa M; Resetkova E; Jamieson C; Tamai H; Volpé R Clin Invest Med; 1997 Feb; 20(1):5-15. PubMed ID: 9013039 [TBL] [Abstract][Full Text] [Related]
17. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model. Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966 [TBL] [Abstract][Full Text] [Related]
18. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Rachakatla RS; Marini F; Weiss ML; Tamura M; Troyer D Cancer Gene Ther; 2007 Oct; 14(10):828-35. PubMed ID: 17599089 [TBL] [Abstract][Full Text] [Related]
19. Effects of IL-12 on human ovarian tumors engrafted into SCID mice. Silver DF; Hempling RE; Piver MS; Repasky EA Gynecol Oncol; 1999 Feb; 72(2):154-60. PubMed ID: 10021294 [TBL] [Abstract][Full Text] [Related]
20. Impact of human neutralizing antibodies on antitumor efficacy of an oncolytic adenovirus in a murine model. Tsai V; Johnson DE; Rahman A; Wen SF; LaFace D; Philopena J; Nery J; Zepeda M; Maneval DC; Demers GW; Ralston R Clin Cancer Res; 2004 Nov; 10(21):7199-206. PubMed ID: 15534093 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]